Format

Send to

Choose Destination
Gastroenterol Hepatol (N Y). 2012 Nov;8(11 Suppl 7):1-16.

Contemporary Diagnostic Strategies for the Detection of Helicobacter pylori Infection.

Author information

1
Associate Head, Division of Gastroenterology and Liver Disease Associate Professor of Medicine Cooper University Hospital Robert Wood Johnson Medical School at Camden Mount Laurel, New Jersey.
2
Professor of Medicine Division of Gastroenterology and Hepatology Northwestern University Feinberg School of Medicine Chicago, Illinois.
3
Chairman of the Department of Medicine Alta Bates Summit Medical Center Oakland, California.

Abstract

Helicobacter pylori infection is highly prevalent, affecting approximately half of the world's population. While the majority of infected individuals are asymptomatic, H. pylori infection is associated with certain diseases, including peptic ulcers (either duodenal or gastric), gastritis, and 2 malignancies-gastric cancer and gastric mucosa-associated lymphoid tissue lymphoma. Many of the epidemiologic associations between these diseases and H. pylori infection have been further validated by treatment studies, which show that effective eradication therapy correlates with a decreased risk of disease. A variety of testing strategies are used to detect H. pylori infection. Serologic techniques are widely available and inexpensive, but they are no longer preferred as they have low sensitivities and specificities, and they may show a positive result for a long period following effective therapy. The remaining testing methods are divided into 2 categories: invasive tests (which require endoscopy) and noninvasive tests. Noninvasive test methods such as the urea breath test and stool antigen test have gained popularity due to their high sensitivities and specificities. Further, both of these methods may be used to confirm the absence of infection following eradication therapy. Due to the increasing incidence of treatment failure (caused in part by antibiotic resistance), post-treatment testing is recommended to confirm H. pylori eradication.

PMID:
24847180
PMCID:
PMC4024247

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center